[1]
|
Understanding HIV/AIDS, Nantional Institute of Allergy and Infectious Diseases.
http://www.niaid.nih.gov/topics/hivaids/understanding/Pages/Default.aspx
|
[2]
|
WHO: Global Summary of AIDS Epidemic, 2009. http://www.who.int/hiv/data/2009_global_summary.png
|
[3]
|
How HIV Causes AIDS, National Nantional Institute of Allergy and Infectious Diseases.
http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/howHIVCausesAIDS/Pages/howhiv.aspx
|
[4]
|
S. M. Hammer, J. Eron Jr, P. Reiss, R. T. Schooley, M. A. Thompson, S. Walmsley, P. Cahn, M. A. Fischl, J. M. Gatell and M. S. Hirsch, “Antiretroviral Treatment of Adult HIV Infection: Recommendations of the International AIDS Society-USA Panel,” Journal of the American Medical Association, Vol. 300, No. 5, 2008, p. 555.
doi:10.1001/jama.300.5.555
|
[5]
|
WHO: HIV/AIDS.
http://www.who.int/features/qa/71/en/index.html
|
[6]
|
WHO: Classification of Low- and Middle-Income Countries by Income Level, Epidemic Level, and Geographical UNAIDS, UNICEF and WHO Regions.
http://www.who.int/hiv/data/tuapr2010_annex7.xls
|
[7]
|
WHO: Treated Patients in Low- and Middle-Income Countries by Income Level, Epidemic Level, and Geographical UNAIDS, UNICEF and WHO Regions. http://www.who.int/hiv/data/tuapr_2010_figures_slideset.pps
|
[8]
|
WHO: Reported Number of People Receiving Antiretroviral Therapy in Low- and Middle-Income Countries by Sex and by Age, and Estimated Number of Children Receiving and Needing Antiretroviral Therapy and Coverage Percentages, 2009.
http://www.who.int/hiv/data/tuapr2010_annex4.xls
|
[9]
|
Adherence and Drug Resistance, Nantional Institute of Allergy and Infectious Diseases.
http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Treatment/Pages/adherence.aspx
|
[10]
|
L. Patrick, “Nutrients and HIV: Part One—Beta Carotene and Selenium,” Alternative Medicine Review: A Journal of Clinical Therapeutic, Vol. 4, No. 6, 1999, p. 403.
|
[11]
|
K. Schwarz and C. M. Foltz, “Selenium as an Integral Part of Factor 3 against Dietary Necrotic Liver Degeneration,” Journal of the American Chemical Society, Vol. 79, No. 12, 1957, pp. 3292-3293. doi:10.1021/ja01569a087
|
[12]
|
P. R. Hoffmann and M. J. Berry, “The Influence of Selenium on Immune Responses,” Molecular Nutrition & Food Research, Vol. 52, No. 11, 2008, pp. 1273-1280.
doi:10.1002/mnfr.200700330
|
[13]
|
M. P. Look, J. K. Rockstroh, G. S. Rao, K. A. Kreuzer, U. Spengler and T. Sauerbruch, “Serum Selenium Versus Lymphocyte Subsets and Markers of Disease Progression and Inflammatory Response in Human Immunodeficiency Virus-1 Infection,” Biological Trace Element Research, Vol. 56, No. 1, 1997, pp. 31-41.
doi:10.1007/BF02778982
|
[14]
|
M. K. Baum, G. Shor-Posner, S. Lai, G. Zhang, H. Lai, M. A. Fletcher, H. Sauberlich and J. B. Page, “High Risk of HIV-Related Mortality is Associated with Selenium Deficiency,” Journal of Acquired Immune Deficiency Syndromes, Vol. 15, No. 5, 1997, p. 370.
doi:10.1097/00042560-199708150-00007
|
[15]
|
R. Kupka, G. I. Msamanga, D. Spiegelman, S. Morris, F. Mugusi, D. J. Hunter and W. W. Fawzi, “Selenium Status is Associated with Accelerated HIV Disease Progression among HIV-1-Infected Pregnant Women in Tanzania,” The Journal of Nutrition, Vol. 134, No. 10, 2004, p. 2556.
|
[16]
|
C. B. Stephensen, G. S. Marquis, S. D. Douglas, L. A. Kruzich and C. M. Wilson, “Glutathione, Glutathione Peroxidase, and Selenium Status in HIV-Positive and HIV-Negative Adolescents and Young Adults,” The American Journal of Clinical Nutrition, Vol. 85, No. 1, 2007, p. 173.
|
[17]
|
G. Shor-Posner, M. J. Miguez, L. M. Pineda, A. Rodriguez, P. Ruiz, G. Castillo, X. Burbano, R. Lecusay and M. Baum, “Impact of Selenium Status on the Pathogenesis of Mycobacterial Disease in HIV-1-Infected Drug Users during the Era of Highly Active Antiretroviral Therapy,” Journal of Acquired Immune Deficiency Syndromes, Vol. 29, No. 2, 2002, p. 169.
|
[18]
|
J. Constans, J. L. Pellegrin, C. Sergeant, M. Simonoff, I. Pellegrin, H. Fleury, B. Leng and C. Conri, “Serum Selenium Predicts Outcome in HIV Infection,” Journal of Acquired Immune Deficiency Syndromes, Vol. 10, No. 3, 1995, p. 392. doi:10.1097/00042560-199511000-00015
|
[19]
|
H. Khalili, A. Soudbakhsh, M. Hajiabdolbaghi, S. DashtiKhavidaki, A. Poorzare, A. Saeedi and R. Sharififar, “Nutritional Status and Serum Zinc and Selenium Levels in Iranian HIV Infected Individuals,” BMC Infectious Diseases, Vol. 8, No. 1, 2008, p. 165.
doi:10.1186/1471-2334-8-165
|
[20]
|
M. C. Delmas-Beauviaux, E. Peuchant, A. Couchouron, J. Constans, C. Sergeant, M. Simonoff, J. L. Pellegrin, B. Leng, C. Conri and M. Clerc, “The Enzymatic Antioxidant System in Blood and Glutathione Status in Human Immunodeficiency Virus (HIV)-Infected Patients: Effects of Supplementation with Selenium or Carotene,” American Journal of Clinical Nutrition, Vol. 64, No. 1, 1996, pp. 101-107.
|
[21]
|
L. Olmsted, G. N. Schrauzer, M. Flores-Arce and J. Dowd, “Selenium Supplementation of Symptomatic Human Immunodeficiency Virus Infected Patients,” Biological Trace Element Research, Vol. 20, No. 1, 1989, pp. 59-65. doi:10.1007/BF02919098
|
[22]
|
P. A. Sandstrom, J. Murray, T. M. Folks and A. M. Diamond, “Antioxidant Defenses Influence HIV-1 Replication and Associated Cytopathic Effects,” Free Radical Biology and Medicine, Vol. 24, No. 9, 1998, pp. 1485-1491. doi:10.1016/S0891-5849(98)00023-9
|
[23]
|
M. Kameoka, T. Kimura and K. Ikuta, “Superoxide Enhances the Spread of HIV-1 Infection by Cell-To-Cell Transmission,” FEBS Letters, Vol. 331, No. 1-2, 1993, pp. 182-186. doi:10.1016/0014-5793(93)80322-L
|
[24]
|
W. Dr?ge, H. P. Eck, H. Gmünder and S. Mihm, “Requirement for Prooxidant and Antioxidant States in T Cell Mediated Immune Responses—Relevance for the Pathogenetic Mechanism of AIDS?” Journal of Molecular Medicine, Vol. 69, No. 21, 1991, pp. 1118-1122.
|
[25]
|
B. E. Hurwitz, N. G. Klimas, M. M. Llabre, K. J. Maher, J. S. Skyler, M. S. Bilsker, S. McPherson-Baker, P. J. Lawrence, A. R. LaPerriere and J. M. Greeson, “HIV, Metabolic Syndrome X, Inflammation, Oxidative Stress, and Coronary Heart Disease Risk,” Cardiovascular Toxicology, Vol. 4, No. 3, 2004, pp. 303-315.
doi:10.1385/CT:4:3:303
|
[26]
|
E. W. Taylor, R. G. Nadimpalli and C. S. Ramanathan, “Genomic Structures of Viral Agents in Relation to the Biosynthesis of Selenoproteins,” Biological Trace Element Research, Vol. 56, No. 1, 1997, pp. 63-91.
doi:10.1007/BF02778984
|
[27]
|
A. Cirelli, M. Ciardi, C. De Simone, F. Sorice, R. Giordano, L. Ciaralli and S. Costantini, “Serum Selenium Concentration and Disease Progress in Patients with HIV Infection,” Clinical Biochemistry, Vol. 24, No. 2, 1991, pp. 211-214. doi:10.1016/0009-9120(91)90601-A
|
[28]
|
X. Burbano, M. Miquez-Burbano, K. McCollister, G. Zhang, A. Rodriguez, P. Ruiz, R. Lecusay and G. Shor-Posner, “Impact of a Selenium Chemoprevention Clinical Trial on Hospital Admissions of HIV-Infected Participants,” HIV Clinical Trials, Vol. 3, No. 6, 2002, pp. 483-491. doi:10.1310/A7LC-7C9V-EWKF-2Y0H
|
[29]
|
B. E. Hurwitz, J. R. Klaus, M. M. Llabre, A. Gonzalez, P. J. Lawrence, K. J. Maher, J. M. Greeson, M. K. Baum, G. Shor-Posner and J. S. Skyler, “Suppression of Human Immunodeficiency Virus Type 1 Viral Load with Selenium Supplementation,” Arch International Medicine, Vol. 167, 2007, pp. 148-154.
doi:10.1001/archinte.167.2.148
|
[30]
|
M. P. Look, J. Rockstroh, G. Rao, S. Barton, H. Lemoch, R. Kaiser, B. Kupfer, T. Sudhop, U. Spengler and T. Sauerbruch, “Sodium Selenite and N-Acetylcysteine in Antiretroviralnaive HIV-1-Infected Patients: A Randomized, Controlled Pilot Study,” European Journal of Clinical Investigation, Vol. 28, No. 5, 1998, pp. 389-397.
doi:10.1046/j.1365-2362.1998.00301.x
|